- Home
- MIRA vs GRF Comparison
MIRA vs GRF Comparison
Compare MIRA & GRF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MIRA | GRF |
|---|---|---|
| Founded | 2020 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 53.2M | 43.9M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | MIRA | GRF |
|---|---|---|
| Price | $1.19 | $10.59 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 119.2K | 1.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 3.70% |
| EPS Growth | ★ 20.31 | N/A |
| EPS | N/A | ★ 1.16 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $9.22 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.81 | $8.86 |
| 52 Week High | $2.45 | $11.85 |
Technical Indicators
Market Signals| Indicator | MIRA | GRF |
|---|---|---|
| Relative Strength Index (RSI) | 42.06 | 46.40 |
| Support Level | $1.14 | $10.43 |
| Resistance Level | $1.35 | $11.01 |
| Average True Range (ATR) | 0.09 | 0.17 |
| MACD | 0.01 | -0.03 |
| Stochastic Oscillator | 45.83 | 23.96 |
Price Performance
Historical ComparisonAbout MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.
About GRF Eagle Capital Growth Fund Inc.
Eagle Capital Growth Fund Inc is a diversified closed-end investment company. The fund's objective is long-term growth utilizing the concept of total return for selecting investments. It seeks to achieve its investment objectives by investing predominantly in U.S. issuer common stock by giving preference to high-quality companies, where high quality denotes substantial operating income margins, high returns on capital, and robust balance sheets.